Search - tctmd.com

Displaying 41 - 59 of 59

Sort: Relevancy | Date

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Conference News ESC 2017

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Michael O'Riordan

August 29, 2017

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

Presentation Fellows 2017

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Gregg W. Stone

April 07, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

Radiation Exposure Greater for Radial vs Femoral PCI, RAD-MATRIX Dosimeter Study Confirms

L.A. McKeown

March 19, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Daily News

特朗普逆转获胜，美国心脏病学家也纷纷震惊

Todd Neale

November 09, 2016

News Daily News

Trump’s Unexpected Win Met With Everything From Shock to Optimism Among US Cardiologists

Todd Neale

November 09, 2016

News Daily News

La Inesperada Victoria de Trump Desata el Estupor y el Optimismo a Partes Iguales entre los Cardiólogos Norteamericanos

Todd Neale

November 09, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

Presentation

TCT 2015 Late Breaking Trials: LEADERS FREE and RESPECT LATE

Presenter: Gregg W. Stone

November 23, 2015

CME

Aspirin for the Interventionalist: More Than Meets the Eye

CME

Advertisement

Long-term Absorb BVS Data Continue to Disappoint

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Antiplatelet Therapy for the Interventionalist

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Radiation Exposure Greater for Radial vs Femoral PCI, RAD-MATRIX Dosimeter Study Confirms

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

特朗普逆转获胜，美国心脏病学家也纷纷震惊

Trump’s Unexpected Win Met With Everything From Shock to Optimism Among US Cardiologists

La Inesperada Victoria de Trump Desata el Estupor y el Optimismo a Partes Iguales entre los Cardiólogos Norteamericanos

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

TCT 2015 Late Breaking Trials: LEADERS FREE and RESPECT LATE

Aspirin for the Interventionalist: More Than Meets the Eye

Everyday Antiplatelet Decisions: Making the Right Choices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content